Medtronic’s Evolut trial outcome could shift US TAVR market
Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction than SAPIEN.

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction than SAPIEN.
Dr Todd Villines at the University of Virginia, US; and Dr Carlos Collet at OLV Hospital, Belgium, will spearhead the study.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
NHS ups AI push with Cera software rollout for fall prediction
Apple UK update transforms AirPods into hearing aids
Scientists develop largest ever biological AI model that ‘thinks in nucleotides’
Why 2025 is a key year for the surgical robotics market